Loading data
PLRZNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development expense | 2.13 m USD | 534 k USD | 332 k USD | 347 k USD |
| Operating profit | -6.25 m USD | -1.3 m USD | -635 k USD | -895 k USD |
| Net income (reported basis) | -3.34 m USD | -1.55 m USD | -600 k USD | -779 k USD |
| Net income attributable to common shareholders | 3.34 m USD | 1.61 m USD | 669 k USD | 823 k USD |
| Basic earnings per share | 4.9 USD/share | 805.2 USD/share | 494.4 USD/share | 0.6 USD/share |
| Diluted earnings per share | 4.9 USD/share | 805.2 USD/share | 494.4 USD/share | 0.6 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.